Pharma companies collaborate on early Alzheimer’s diagnoses

Roche has announced its collaboration with its counterpart Eli Lilly to try to achieve early diagnosis of Alzheimer’s disease using the diagnostic Elecsys Amyloid Plasma Panel – testing blood plasma for key Alzheimer’s disease markers.

Redefining clinical meaningfulness

A World Dementia Council Summit will this week (Monday) discuss how teams conducting clinical research into Alzheimer’s disease and wider dementia can measure what matters when some interventions clearly benefit patients but may not deliver the dramatic improvements needed to meet current definitions of effectiveness.

Dementia: A treatable condition of midlife

One of the world’s foremost researchers into Alzheimer’s Disease and the wider diagnosis and treatment of dementia says, for the last century, investigations into these conditions have been focusing on the wrong place.